More than 50 guests attended the Massachusetts General Hospital private cocktail reception hosted by the Rendina Family Foundation. Drs. Loeffler, Ryan, Curry, Flaherty, Hong and Pirl mingled with guests and gave a short presentation about the latest in oncology at the Massachusetts General Hospital Cancer Center.Jay Loeffler, MD, Radiation OncologyChief, Radiation OncologyDr. Loeffler is the Herman and Joan Suit Professor of Radiation Oncology and was recently honored as a Fellow at the American Society of Therapeutic Radiation and Oncology in 2009. Dr. Loeffler’s clinical interests include adult malignant and benign brain tumors, proton radiotherapy, stereotactic and conformal radiation techniques and biochemical modifications of radiation effects in glioma.David Ryan, MD, Medical OncologyDeputy Chief of Hematology Oncology for Clinical AffairsClinical Director, Gosnell Center for Gastrointestinal CancersThe principal focus of Dr. Ryan’s clinical research is the design and implementation of Phases I and II trials in gastrointestinal malignancies.William Curry, MD, Neurosurgical OncologyDirector, Neurosurgical EducationAttending NeurosurgeonDr. Curry’s clinical focus is on the surgical treatment of patients with benign and malignant tumors of the brain, skull base, and spine. His primary research focus is on the development of vaccine therapy for malignant brain tumors, malignant tumors of the brain, spine and spinal cord and also in neurofibromatosis and immunotherapy for brain tumors.Keith Flaherty, MD, Medical OncologyDirector, Developmental TherapeuticsDr. Flaherty’s research and clinical focus is therapies for melanoma and renal cell carcinoma (RCC), with a particular expertise in targeted therapies.Theodore Hong, MD, Radiation OncologyDirector, Gastrointestinal Radiation OncologyDr. Hong’s primary focus is GI radiation oncology. In addition to his clinical activities, he is responsible for radiation oncology resident education in GI cancers.William Pirl, MD, MPH, Supportive ServicesDirector, Center for Psychiatric Oncology and Behavioral SciencesIn September of 2009, Dr. Pirl was appointed as the first Director of Psychiatric Oncology and Behavioral Sciences at the Mass General Cancer Center, formally organizing the clinical, educational, and research efforts of psychiatry and psychology in the Cancer Center.